Not recruiting
Obesity
Not recruitingInvestigational
A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
Investigational
- Substances:–
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
Find therapies in clinical trials near you – page 6
- recruiting
- 3 961
- countries
- 28
- conditions
- 2 103
3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today
116 trials match your criteria
Not recruiting
Obesity+3
Not recruitingRegistered drug
A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
Registered drug
- Substances:CagrilintideEnalapril Maleate+3
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Cagrilintide
Not recruiting
Obesity+2
Not recruitingInvestigational
A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
Investigational
- Substances:CagrilintideSemaglutide
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Cagrilintide
Not recruiting
Obesity+2
Not recruitingInvestigational
Study of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes
Investigational
- Substances:–
Countries:
Czechia
Czechia- Participants:18–64 years
Not recruiting
Obesity+1
Not recruitingInvestigational
Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes
Investigational
- Substances:Maridebart Cafraglutide
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Maridebart Cafraglutide
Not recruiting
Obesity
Not recruitingInvestigational
Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
Investigational
- Substances:BI 456906SURVODUTIDE
Countries:Austria
Austria- Participants:18–64 years · 65+ years
- Substances:BI 456906
Not recruiting
Obesity+2
Not recruitingInvestigational
Study of Retatrutide for Patients with Obesity, Overweight, and Chronic Low Back Pain
Investigational
- Substances:Ly3437943 Sodium
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Ly3437943 Sodium
Not recruiting
Obesity
Not recruitingInvestigationalNo placebo
Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
InvestigationalNo placebo
- Substances:CagrilintideSemaglutide
Countries:Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Cagrilintide
Not recruiting
Obesity
Not recruitingInvestigational
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
Investigational
- Substances:HRS 9531
Countries:Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:HRS 9531
Not recruiting
Obesity
Not recruitingInvestigational
A study to evaluate the efficacy and safety of zenagamtide in people with obesity
Investigational
- Substances:–
Countries:Belgium
Belgium- Participants:18–64 years
Not recruiting
Obesity
Not recruitingRegistered drugNo placebo
Orlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity
Registered drugNo placebo
Countries:
Sweden
Sweden- Participants:18–64 years · Healthy volunteers
- Substances:ACARBOSE
Not recruiting
Obesity+1
Not recruitingRegistered drug
Phase 1 randomized, placebo-controlled study of ROSE-010 and paracetamol on appetite in overweight and obese adults
Registered drug
- Substances:Paracetamol
Countries:Sweden
Sweden- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Paracetamol